Bielicki, Julia
10 papers on CoChatORCID 0000-0002-3902-5489
Most cited papers
- Verified
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 16,316
- Verified
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 3,791
- Verified
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science
interferon and immune responsesSARS-CoV-2 and COVID-19 Research
Cited by 2,662
- Verified
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science
interferon and immune responsesSARS-CoV-2 and COVID-19 Research
Cited by 2,229
- Verified
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R.-M. V., Novotney, A., Wool, E. E., Ikuta, K. S., Vongpradith, A., Rogowski, E. L. B., Doxey, M., et al. (2024) · The Lancet Infectious Diseases
Pneumonia and Respiratory InfectionsRespiratory viral infections research
Cited by 596
- Verified
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis
Sartorius, B., Gray, A. P., Davis Weaver, N., Robles Aguilar, G., Swetschinski, L. R., Ikuta, K. S., Mestrovic, T., Chung, E., Wool, E. E., Han, C., et al. (2024) · The Lancet Global Health
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 354
- Verified
Systematic review of antibiotic resistance rates among Gram-negative bacteria in children with sepsis in resource-limited countries
Le Doare, K., Bielicki, J., Heath, P. T., & Sharland, M. (2015) · Journal of the Pediatric Infectious Diseases Society
Antibiotic Resistance in BacteriaAntibiotic Use and Resistance
Cited by 156
- Verified
Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network
Li, G., Bielicki, J. A., Ahmed, A. S. M. N. U., Islam, M. S., Berezin, E. N., Gallacci, C. B., Guinsburg, R., da Silva Figueiredo, C. E., Santarone Vieira, R., Silva, A. R., et al. (2020) · Archives of Disease in Childhood
Neonatal and Maternal InfectionsAntibiotic Use and Resistance
Cited by 106
- Verified
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group
Schweitzer, V. A., van Werkhoven, C. H., Rodríguez Baño, J., Bielicki, J., Harbarth, S., Hulscher, M., Huttner, B., Islam, J., Little, P., Pulcini, C., et al. (2020) · Clinical Microbiology and Infection
Antibiotic Use and ResistanceHealth Policy Implementation Science
Cited by 73
- Verified
High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries
Bortone, B., Jackson, C., Hsia, Y., Bielicki, J., Magrini, N., & Sharland, M. (2021) · PLoS ONE
Antibiotic Use and ResistancePharmaceutical Economics and Policy
Cited by 54
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free